Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activity - PubMed (original) (raw)
. 2001 Oct 1;49(2):145-54.
doi: 10.1002/pros.1129.
Affiliations
- PMID: 11582594
- DOI: 10.1002/pros.1129
Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activity
A Rimler et al. Prostate. 2001.
Abstract
Background: The androgen receptor (AR) promotes growth and functionality of androgen sensitive benign and cancer tissues. The pineal hormone melatonin is an androgen protagonist in vivo and in vitro. The interference of melatonin in the AR cascade was explored.
Methods: The effects of melatonin on AR expression, level, agonist and androgen-response element (ARE) binding, reporter gene activity and intracellular localization were explored in prostate cancer LNCaP cell line.
Results: Melatonin increased immunoreactive AR cells in the absence and presence of dihydrotestosterone. Despite this increase and maintenance of AR agonist binding capacity, the androgen-induced reporter gene activity and suppression of AR-mRNA were attenuated. Immunocytochemical analysis and subcellular fractionation studies revealed nuclear exclusion of AR by melatonin.
Conclusions: The melatonin-mediated nuclear exclusion of the AR may explain the attenuation of AR activity in the prostate cancer cells. This is the first demonstration of a hormone-induced mislocalization of the AR in prostate epithelial cells and may represent a novel route for regulating AR activity.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
- The inhibitory effect of melatonin on human prostate cancer.
Shen D, Ju L, Zhou F, Yu M, Ma H, Zhang Y, Liu T, Xiao Y, Wang X, Qian K. Shen D, et al. Cell Commun Signal. 2021 Mar 15;19(1):34. doi: 10.1186/s12964-021-00723-0. Cell Commun Signal. 2021. PMID: 33722247 Free PMC article. Review. - Differential regulation by melatonin of cell growth and androgen receptor binding to the androgen response element in prostate cancer cells.
Rimler A, Lupowitz Z, Zisapel N. Rimler A, et al. Neuro Endocrinol Lett. 2002 Apr;23 Suppl 1:45-9. Neuro Endocrinol Lett. 2002. PMID: 12019351 - Nuclear exclusion of the androgen receptor by melatonin.
Rimler A, Culig Z, Lupowitz Z, Zisapel N. Rimler A, et al. J Steroid Biochem Mol Biol. 2002 May;81(1):77-84. doi: 10.1016/s0960-0760(02)00050-x. J Steroid Biochem Mol Biol. 2002. PMID: 12127045 - Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP.
Zhu W, Zhang JS, Young CY. Zhu W, et al. Carcinogenesis. 2001 Sep;22(9):1399-403. doi: 10.1093/carcin/22.9.1399. Carcinogenesis. 2001. PMID: 11532861 - The Potential Oncostatic Effects of Melatonin against Prostate Cancer.
Samanta S. Samanta S. Crit Rev Oncog. 2021;26(3):53-67. doi: 10.1615/CritRevOncog.2021041260. Crit Rev Oncog. 2021. PMID: 35377986 Review.
Cited by
- Expression and putative functions of melatonin receptors in malignant cells and tissues.
Ekmekcioglu C. Ekmekcioglu C. Wien Med Wochenschr. 2014 Nov;164(21-22):472-8. doi: 10.1007/s10354-014-0289-6. Epub 2014 Jul 15. Wien Med Wochenschr. 2014. PMID: 25023005 Review. - Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers.
Menéndez-Menéndez J, Martínez-Campa C. Menéndez-Menéndez J, et al. Int J Endocrinol. 2018 Oct 2;2018:3271948. doi: 10.1155/2018/3271948. eCollection 2018. Int J Endocrinol. 2018. PMID: 30386380 Free PMC article. Review. - Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
Lo Sardo F, Muti P, Blandino G, Strano S. Lo Sardo F, et al. Int J Mol Sci. 2017 Sep 6;18(9):1913. doi: 10.3390/ijms18091913. Int J Mol Sci. 2017. PMID: 28878191 Free PMC article. - Prostate cancer mortality risk in relation to working underground in the Wismut cohort study of German uranium miners, 1970-2003.
Walsh L, Dufey F, Tschense A, Schnelzer M, Sogl M, Kreuzer M. Walsh L, et al. BMJ Open. 2012 Jun 8;2(3):e001002. doi: 10.1136/bmjopen-2012-001002. Print 2012. BMJ Open. 2012. PMID: 22685223 Free PMC article. - The inhibitory effect of melatonin on human prostate cancer.
Shen D, Ju L, Zhou F, Yu M, Ma H, Zhang Y, Liu T, Xiao Y, Wang X, Qian K. Shen D, et al. Cell Commun Signal. 2021 Mar 15;19(1):34. doi: 10.1186/s12964-021-00723-0. Cell Commun Signal. 2021. PMID: 33722247 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials